Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Credit agrmnt [a] Appointed CFO Quarterly results Director departure CC transcript
|
Anika Therapeutics, Inc. (ANIK)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/09/2021 |
GN
| Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021 |
10/22/2020 |
GN
| Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4, 2020 |
10/21/2020 |
GN
| Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacement of Painful Wrist Joints |
09/08/2020 |
GN
| Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors |
09/03/2020 |
GN
| Anika to Participate in Upcoming Virtual Investor Conferences |
08/05/2020 |
GN
| Anika Appoints Michael Levitz as Chief Financial Officer |
07/20/2020 |
GN
| Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020 |
07/16/2020 |
GN
| Anika to Issue Second Quarter 2020 Financial Results and Business Highlights on Thursday, July 30 |
02/20/2020 |
GN
| Anika Reports Fourth Quarter and Full Year 2019 Financial Results |
01/29/2020 |
GN
| Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer |
11/21/2019 |
GN
| Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class Wireless, User-Controlled Drug Delivery Platform |
04/08/2019 |
GN
| Recent Analysis Shows Renewable Energy Group, Winnebago Industries, Ambac Financial Group, Hibbett Sports, AmeriGas Partners, and Anika Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth |
02/01/2019 |
GN
| New Research: Key Drivers of Growth for Cisco, Landstar System, Central Garden & Pet, Anika Therapeutics, Hibbett Sports, and MoneyGram International — Factors of Influence, Major Initiatives and Sustained Production |
08/07/2018 |
GN
| Analysis: Positioning to Benefit within Anika Therapeutics, Ameris, Century Communities, Energous, Consolidated Communications, and Globalstar — Research Highlights Growth, Revenue, and Consolidated Results |
05/01/2018 |
GN
| Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical — Future Expectations, Projections Moving into 2018 |
03/05/2018 |
GN
| Joseph Darling Named CEO and Director of Anika Therapeutics |
01/22/2018 |
GN
| Recent Analysis Shows Darling Ingredients, Principal Financial Group, UGI, Cass Information, WD-40, and Anika Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth |
02/27/2017 |
GN
| Anika Therapeutics, Inc., (Nasdaq: ANIK) to Ring The Nasdaq Stock Market Opening Bell |
|
|